Free Trial

Eledon Pharmaceuticals (ELDN) Short Interest Ratio & Short Volume

Eledon Pharmaceuticals logo
$3.85 -0.03 (-0.77%)
(As of 11/20/2024 ET)

Eledon Pharmaceuticals Short Interest Data

Eledon Pharmaceuticals (ELDN) has a short interest of 960,600 shares. This marks a 572.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 198,213 shares to cover all short positions.

Current Short Interest
960,600 shares
Previous Short Interest
142,900 shares
Change Vs. Previous Month
+572.22%
Dollar Volume Sold Short
$4.47 million
Short Interest Ratio
2.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
39,656,000 shares
Percentage of Shares Shorted
2.42%
Today's Trading Volume
423,612 shares
Average Trading Volume
198,213 shares
Today's Volume Vs. Average
214%
Short Selling Eledon Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ELDN Short Interest Over Time

ELDN Days to Cover Over Time

ELDN Percentage of Float Shorted Over Time

Eledon Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024960,600 shares $4.47 million +572.2%N/A2.9 $4.65
10/15/2024142,900 shares $421,555.00 +20.5%N/A2.2 $2.95
9/30/2024118,600 shares $295,314.00 +42.4%N/A1.6 $2.49
9/15/202483,300 shares $220,745.00 -29.4%N/A1 $2.65
8/31/2024117,900 shares $331,299.00 +17.1%N/A1.2 $2.81
8/15/2024100,700 shares $275,918.00 -6.9%N/A0.8 $2.74
7/31/2024108,100 shares $317,814.00 -16.1%N/A0.7 $2.94
7/15/2024128,800 shares $336,168.00 -24.5%N/A0.6 $2.61
6/30/2024170,600 shares $450,384.00 +225.6%N/A0.8 $2.64
6/15/202452,400 shares $158,772.00 +7.4%N/A0.2 $3.03
5/31/202448,800 shares $134,200.00 -74.5%N/A0.2 $2.75
5/15/2024191,500 shares $479,707.50 +441.0%N/A1 $2.51
4/30/202435,400 shares $84,606.00 +13.8%N/A0.2 $2.39
4/15/202431,100 shares $51,004.00 -70.9%N/A0.3 $1.64
3/31/2024106,900 shares $220,214.00 +193.7%N/A1.4 $2.06
3/15/202436,400 shares $56,056.00 -6.7%N/A0.5 $1.54
2/29/202439,000 shares $70,200.00 -26.7%N/A0.6 $1.80
2/15/202453,200 shares $97,356.00 -11.8%N/A0.8 $1.83
1/31/202460,300 shares $107,334.00 -15.6%N/A0.8 $1.78
1/15/202471,400 shares $123,529.14 +37.3%N/A0.8 $1.73
12/31/202352,000 shares $93,600.00 -20.4%N/A0.6 $1.80
12/15/202365,300 shares $99,256.00 +147.4%N/A0.7 $1.52
11/30/202326,400 shares $30,360.00 -59.9%N/A0.3 $1.15
11/15/202365,900 shares $82,375.00 +25.8%N/A0.7 $1.25
10/31/202352,400 shares $81,744.00 +5.2%N/A0.6 $1.56
10/15/202349,800 shares $73,704.00 -20.1%N/A0.7 $1.48
9/30/202362,300 shares $85,351.00 +92.3%N/A0.9 $1.37
9/15/202332,400 shares $40,500.00 +18.7%N/A0.6 $1.25
8/31/202327,300 shares $41,496.00 -34.4%N/A0.5 $1.52
8/15/202341,600 shares $50,752.00 +1.2%N/A0.5 $1.22
7/31/202341,100 shares $56,718.00 +18.1%N/A0.3 $1.38
7/15/202334,800 shares $50,112.00 -4.1%N/A0.2 $1.44
6/30/202336,300 shares $49,731.00 -85.1%N/A0.2 $1.37
6/15/2023244,200 shares $402,930.00 +383.6%2.0%1.3 $1.65
5/31/202350,500 shares $106,050.00 +136.0%0.4%0.3 $2.10
5/15/202321,400 shares $49,648.00 -62.6%0.2%0.1 $2.32
4/30/202357,200 shares $120,120.00 +276.3%0.4%0.5 $2.10
4/15/202315,200 shares $37,088.00 -47.0%0.1%0.6 $2.44
3/31/202328,700 shares $67,732.00 +64.9%0.2%1.1 $2.36
3/15/202317,400 shares $34,974.00 +4.2%0.1%0.8 $2.01
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

2/28/202316,700 shares $39,412.00 -9.2%0.1%1 $2.36
2/15/202318,400 shares $49,864.00 +8.2%0.1%1.2 $2.71
1/31/202317,000 shares $56,440.00 +6.3%0.1%1.1 $3.32
1/15/202316,000 shares $45,561.60 +11.9%0.1%1.1 $2.85
12/30/202214,300 shares $32,604.00 +19.2%0.1%0.7 $2.28
12/15/202212,000 shares $28,972.80 -39.7%0.1%0.6 $2.41
11/30/202219,900 shares $48,556.00 -20.1%0.1%1 $2.44
11/15/202224,900 shares $65,736.00 +69.4%0.2%1.1 $2.64
10/31/202214,700 shares $35,427.00 -2.0%0.1%0.6 $2.41
10/15/202215,000 shares $37,992.00 -29.9%0.1%0.6 $2.53
9/30/202221,400 shares $59,064.00 -4.9%0.2%0.7 $2.76
9/15/202222,500 shares $76,500.00 -17.6%0.2%0.7 $3.40
8/31/202227,300 shares $102,375.00 +31.3%0.2%0.5 $3.75
8/15/202220,800 shares $73,632.00 +181.1%0.2%0.3 $3.54
7/31/20227,400 shares $22,274.00 -10.8%0.1%0.1 $3.01
7/15/20228,300 shares $24,900.00 +31.8%0.1%0.1 $3.00
6/30/20226,300 shares $15,372.00 -84.9%0.1%0.1 $2.44
6/15/202241,600 shares $122,304.00 +4.3%0.3%0.8 $2.94
5/31/202239,900 shares $127,281.00 +250.0%0.3%0.9 $3.19
5/15/202211,400 shares $30,220.26 -22.5%0.1%0.4 $2.65
4/30/202214,700 shares $44,982.00 +107.0%0.1%0.5 $3.06
4/15/20227,100 shares $21,513.00 -93.9%0.1%0.2 $3.03
3/31/2022115,700 shares $455,858.00 -6.5%N/A1.5 $3.94
3/15/2022123,700 shares $379,759.00 -12.6%0.9%1.5 $3.07
2/28/2022141,600 shares $499,848.00 -23.0%1.0%1.5 $3.53
2/15/2022184,000 shares $772,800.00 +6.6%1.3%1.9 $4.20
1/31/2022172,600 shares $699,030.00 +39.2%1.2%1.6 $4.05
1/15/2022124,000 shares $549,320.00 +1.8%N/A0 $4.43
12/31/2021121,800 shares $537,138.00 -12.0%0.9%1.6 $4.41
12/15/2021138,400 shares $596,504.00 -21.5%1.0%1.8 $4.31
11/30/2021176,400 shares $862,596.00 -1.7%1.2%2.1 $4.89
11/15/2021179,500 shares $998,020.00 -15.7%1.3%2.2 $5.56
10/29/2021212,900 shares $1.06 million +14.0%1.5%2.7 $5.00
10/15/2021186,700 shares $1.05 million -26.0%1.3%2.5 $5.63
9/30/2021252,300 shares $1.56 million +89.8%1.8%3.1 $6.18
9/15/2021132,900 shares $930,300.00 +0.2%0.9%1.8 $7.00
8/31/2021132,600 shares $1.10 million -5.6%0.9%1.9 $8.32
8/13/2021140,500 shares $878,125.00 -15.0%1.0%2.1 $6.25
7/30/2021165,300 shares $1.07 million -64.0%1.2%2.9 $6.49
7/15/2021459,000 shares $3.28 million -2.7%3.2%8.9 $7.14
6/30/2021471,900 shares $3.73 million +187.0%3.3%11.9 $7.91
6/15/2021164,400 shares $1.34 million -5.2%1.2%3.5 $8.15
5/28/2021173,500 shares $1.65 million -11.6%1.2%3.6 $9.52
5/14/2021196,200 shares $1.73 million -4.5%1.4%3.6 $8.80
4/30/2021205,400 shares $2.05 million -4.5%1.4%3.3 $9.96
4/15/2021215,000 shares $2.46 million +17.0%N/A0 $11.43
3/31/2021183,700 shares $1.81 million +22.0%1.3%2.7 $9.85
3/15/2021150,600 shares $2.08 million +8.0%13.9%2.1 $13.81
2/26/2021139,400 shares $2.30 million +23.9%12.9%2.4 $16.50
2/12/2021112,500 shares $2.13 million +20.7%10.4%2.4 $18.94
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

1/29/202193,200 shares $1.35 million +6.4%8.6%2.2 $14.53
1/15/202187,600 shares $1.25 million No Change8.1%2.1 $14.25

ELDN Short Interest - Frequently Asked Questions

What is Eledon Pharmaceuticals' current short interest?

Short interest is the volume of Eledon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 960,600 shares of ELDN short. Learn More on Eledon Pharmaceuticals' current short interest.

What is a good short interest ratio for Eledon Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELDN shares currently have a short interest ratio of 3.0. Learn More on Eledon Pharmaceuticals's short interest ratio.

Is Eledon Pharmaceuticals' short interest increasing or decreasing?

Eledon Pharmaceuticals saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 960,600 shares, an increase of 572.2% from the previous total of 142,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Eledon Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Eledon Pharmaceuticals: Oculis Holding AG (0.06%), Tourmaline Bio, Inc. (10.44%), Stoke Therapeutics, Inc. (12.65%), Phathom Pharmaceuticals, Inc. (25.52%), Immunome, Inc. (21.37%), IGM Biosciences, Inc. (16.29%), ChromaDex Co. (5.39%), Altimmune, Inc. (32.26%), GH Research PLC (6.27%), Sana Biotechnology, Inc. (28.18%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Eledon Pharmaceuticals stock?

Short selling ELDN is an investing strategy that aims to generate trading profit from Eledon Pharmaceuticals as its price is falling. ELDN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eledon Pharmaceuticals?

A short squeeze for Eledon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELDN, which in turn drives the price of the stock up even further.

How often is Eledon Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELDN, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ELDN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners